Home » GVK Biosciences Licenses Biomarker Database to NCI

GVK Biosciences Licenses Biomarker Database to NCI

Sep 04, 2012
|
a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Indian contract research organization GVK Biosciences today announced the licensing of its clinical biomarker database to the National Institutes of Health's National Cancer Institute.

The database called GOBIOM is being licensed to NCI's Division of Cancer Prevention. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Jan 21, 2015

Phoenix Bioinformatics Finds User-based Support Model Viable to Sustain TAIR

Premium
Feb 25, 2015

LifeMap Signs Promotional Partnership with Toldot

Feb 10, 2015

COSMIC to Implement Commercial Licensing Option to Support Resource Expansion Plans

Premium
Dec 18, 2014

UPenn, UGA Receive $23.4M for Pathogen Genome Database

Nov 18, 2014

Illumina, BioMérieux Collaborate on NGS-based Applications for Microbiology

Mar 03, 2015

Blueprint Medicines Inks Deal with Alexion Targeting Rare Genetic Disease

The Scan

This Week in PNAS

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

Leaving It All Over Town

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

Balance of Research and Privacy

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

What We'd Do With the Money

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

What's Popular?

In Informatics

  1. RGI Launches Rare Disease Research Challenge

  2. Amyris, Genome Compiler Collaborate on DNA Construction Software Services for Pharma, Biotech

  3. TGAC Partners with Optalysys to Apply Optical Processing Tech to Genomic Sequence Search

    Premium

  4. Roche Acquires Bina Technologies

  5. Now Part of AstraZeneca, Definiens Concentrating on CDx, Ramp up into Clinical Space

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.